Abacavir Sulfate; Lamivudine; Zidovudine Patent Expiration
Abacavir Sulfate; Lamivudine; Zidovudine is Used for treating patients infected with HIV. It was first introduced by Viiv Healthcare Co
Abacavir Sulfate; Lamivudine; Zidovudine Patents
Given below is the list of patents protecting Abacavir Sulfate; Lamivudine; Zidovudine, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Trizivir |
US6294540 (Pediatric) | Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
Nov 14, 2018
(Expired) | Viiv Hlthcare |
Trizivir | US6294540 | Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
May 14, 2018
(Expired) | Viiv Hlthcare |
Trizivir |
US5905082 (Pediatric) | Crystalline oxathiolane derivatives |
Nov 18, 2016
(Expired) | Viiv Hlthcare |
Trizivir |
US6417191 (Pediatric) | Synergistic combinations of zidovudine, 1592U89 and 3TC |
Sep 28, 2016
(Expired) | Viiv Hlthcare |
Trizivir | US5905082 | Crystalline oxathiolane derivatives |
May 18, 2016
(Expired) | Viiv Hlthcare |
Trizivir | US6417191 | Synergistic combinations of zidovudine, 1592U89 and 3TC |
Mar 28, 2016
(Expired) | Viiv Hlthcare |
Abacavir Sulfate; Lamivudine; Zidovudine's Family Patents

Explore Our Curated Drug Screens
Abacavir Sulfate; Lamivudine; Zidovudine Generic API Manufacturers
Only one generic application has been filed for Abacavir Sulfate; Lamivudine; Zidovudine.
Given below is the list of companies who have filed for Abacavir Sulfate; Lamivudine; Zidovudine generic, along with the locations of their manufacturing plants worldwide.
1. LUPIN LTD
Lupin Ltd has filed for 1 generic for Abacavir Sulfate; Lamivudine; Zidovudine. This eq 300mg base;150mg;300mg version comes by the name ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 300MG BASE; 150MG; 300MG
(reference standard) | tablet | Prescription | ORAL | N/A | Dec 5, 2013 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|